### 36784 Federal Register / Vol. 78, No. 118 / Wednesday, June 19, 2013 / Notices

of informed consent issues in cluster randomized trials. After lunch, there will be a special expert panel discussing Certificates of Confidentiality (COCs).

Following opening remarks on the morning of July 11, the Subpart A Subcommittee (SAS) will give their report. This will be followed by a discussion of the concept of engagement in human subjects research. SAS is charged with developing recommendations for consideration by SACHRP regarding the application of subpart A of 45 CFR part 46 in the current research environment; this Subcommittee was established by SACHRP in October 2006. The day will conclude with a panel discussion of issues surrounding electronic informed
consent.

Public attendance at the meeting is limited to space available. Individuals who plan to attend the meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact persons. Members of the public will have the opportunity to provide comments on both days of the meeting. Public comment will be limited to five minutes per speaker. Any members of the public who wish to have printed materials distributed to SACHRP members for this scheduled meeting should submit materials to the Executive Director, SACHRP, prior to the close of business July 5, 2013.

Dated: June 12, 2013. Jerry Menikoff, Director, Office for Human Research Protections, Executive Secretary, Secretary’s Advisory Committee on Human Research Protections.
[FR Doc. 2013–14518 Filed 6–18–13; 8:45 am]

**BILLING CODE 4150–36–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Centers for Disease Control and Prevention (CDC)** 

**[CDC–2013–0010, Docket Number NIOSH– 265]** 

**Survey of Nanomaterial Risk Management Practices** 

**AGENCY :**  National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

**ACTION :**  Proposed NIOSH Survey of Nanomaterial Risk Management Practices; Notice of Public Meeting and Request for Comments.

**SUMMARY :**  The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) announces a public meeting and opportunity for comment on a proposed NIOSH survey. The primary purpose of the survey is to evaluate the use of NIOSH guidelines and risk mitigation practices for safe handling of engineered nanomaterials (ENMs) in the workplace. Information collected from the survey will be useful in future revisions of the guidelines. The public is invited to comment on the proposed survey through a public docket and/or participation in a one-day public meeting.

To view the notice and related materials, visit http:// www.regulations.gov and enter CDC– 2013–0010 in the search field and click ‘‘Search.’’

Public comment period: Submit either electronic or written comments by September 15, 2013.

Registration to attend the meeting must be received by July 17, 2013 and will be accepted on a first come first served basis. See the **SUPPLEMENTARY**
**INFORMATION** section for information on how to register for the meeting.

**ADDRESSES :**  The public meeting will be held at the NIOSH Alice Hamilton building, 5555 Ridge Avenue, Cincinnati, OH 45213. The public meeting will be held on July 31, 2013, from 8 a.m. to 3:00 p.m. EDT.

Security Considerations: Due to mandatory security clearance procedures at the NIOSH Alice Hamilton building, in-person attendees must present valid government-issued picture identification to security personnel upon entering the parking lot.

Non-U.S. citizens: Because of CDC Security Regulations, any non-U.S. citizen wishing to attend this meeting must provide the following information in writing to the NIOSH Docket Officer at the address below no later than June 29, 2013 to allow time for mandatory CDC facility security clearance procedures to be completed.

1. Name: 2. Gender: 3. Date of Birth: 4. Place of birth (city, province, state, country): 5. Citizenship: 6. Passport Number: 7. Date of Passport Issue: 8. Date of Passport Expiration: 9. Type of Visa: 10. U.S. Naturalization Number (if a naturalized citizen): 11. U.S. Naturalization Date (if a naturalized citizen): 12. Visitor’s Organization: 13. Organization Address: 14. Organization Telephone Number: 15. Visitor’s Position/Title within the Organization: This information will be transmitted to the CDC Security Office for approval. Visitors will be notified as soon as approval has been obtained.

You may submit comments, identified by CDC–2013–0010 and Docket Number NIOSH–265, by either of the following two methods:

• Federal eRulemaking Portal: http:// www.regulations.gov. Follow the instructions for submitting comments.

• Mail: NIOSH Docket Office, Robert A. Taft Laboratories, 4676 Columbia Parkway, MS C–34, Cincinnati, Ohio
45226.

Instructions: All information received in response to this notice must include the agency name and docket number (CDC–2013–0010; NIOSH–265). All relevant comments received will be posted without change to http:// www.regulations.gov, including any personal information provided. All electronic comments should be formatted as Microsoft Word. Please make reference to CDC–2013–0010 and Docket Number NIOSH–265.

**SUPPLEMENTARY INFORMATION :**  Attendance: The meeting is open to the public, limited only by the capacity (80) of the conference room. Confirm your attendance to this meeting by sending an email to jun1@cdc.gov by July 17, 2013. An email confirming registration will be sent from NIOSH and will include details needed to participate. Oral comments given at the meeting will be recorded and included in the NIOSH Docket Number 265.

Background: NIOSH is among the world’s leaders in promoting the safe and responsible development and use of ENMs. NIOSH has published guidelines on the safe use of ENMs including ‘‘Approaches to Safe Nanotechnology: Managing the Health and Safety Concerns Associated with Engineered Nanomaterials’’ (http://www.cdc.gov/ niosh/docs/2009–125/pdfs/2009– 125.pdf ) and ‘‘General Safe Practices for Working With Engineered Nanomaterials in Research Laboratories’’ ( http://www.cdc.gov/ niosh/docs/2012–147/pdfs/2012– 147.pdf ). Other organizations in the U.S. and around the world have also developed guidelines for the safe use of ENMs. The proposed survey will examine the extent to which these and other guidelines are implemented and the barriers to using the guidelines.


### 36785 Federal Register / Vol. 78, No. 118 / Wednesday, June 19, 2013 / Notices

A draft questionnaire is available for review at http://www.regulations.gov. NIOSH requests public input on the content of the questionnaire and consideration of the following:

(1) Apart from a survey, what alternative methods should be considered to gather this information?

(2) What resources are available that can be used to identify nanomaterial producers, distributors, end-users, and R&D laboratories for inclusion in a sampling frame?

(3) A web-based survey is beingproposed primarily because it is costefficient and can be easy to administer. Should any other modes (telephone, mail) be considered?

(4) In small and medium-sized establishments, who would be the person best suited to respond to questions addressing risk management practices for ENMs?

(5) What should be the maximum amount of time needed to complete the survey?

(6) Is benchmarking adherence to safe use guidelines of value to your organization?

(7) What guidelines are being used by your organization to minimize worker exposure to ENMs?

(8) Are there any questions in the draft survey that should be excluded? Are there any questions not included in the draft survey that should be included?

**FOR FURTHER INFORMATION CONTACT :**  Jim Boiano—jboiano@cdc.gov; 513–841– 4246 or Rebecca Tsai—rtsai@cdc.gov; 513–841–4398, NIOSH, 4676 Columbia Parkway, Mail Stop R17, Cincinnati, Ohio 45226–1998.

Dated: June 13, 2013. John Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention.
[FR Doc. 2013–14564 Filed 6–18–13; 8:45 am]

**BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND**  **HUMAN SERVICES**

**Centers for Disease Control and Prevention** 

**Disease, Disability, and Injury Prevention and Control Special**  **Emphasis Panel (SEP): Initial Review**

The meeting announced below concerns Centers for Disease Control and Prevention Public Health Preparedness and Response Research to Aid Recovery from Hurricane Sandy, Request for Application (RFA) TP13– 001, initial review.

Correction: The notice was published in the Federal Register on June 11, 2013, Volume 78, Number 112, Pages 35035—35036. The time, date and place should read as follows:

Time and Date: 12:00 p.m.–5:00 p.m. (EST), July 10, 2013 (Closed).

Place: Teleconference. Contact Person for More Information: Shoukat Qari, D.V.M., Ph.D., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop K72, Atlanta, Georgia 30333, Telephone: (770) 488–8808.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dana Redford, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2013–14541 Filed 6–18–13; 8:45 am]

**BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND**  **HUMAN SERVICES**

**Administration for Children and Families** 

**Submission for OMB Review; Comment Request** 

Title: National Medical Support Notice

OMB No.: 0970–0222 Description: The National Medical Support Notice (NMSN) is a two-part document that requires information from State child support enforcement agencies, employers, and health plan administrators to assist in enforcing health care coverage provisions in a child support order. The Department of Health and Human Services (DHHS), Administration for Children and Families (ACF) developed and maintains Part A of the NMSN, which is sent to an obligor’s employer for completion; the Department of Labor (DOL) developed and maintains Part B of the NMSN, which is provided to health care administrators following completion of Part A.

DOL revised Part B to conform with changes to the currently approved Part A and is seeking a three year approval from OMB. To avoid burdening the State child support enforcement agencies with potential reprogramming at varying times due to future changes in either Part A or Part B, ACF is resubmitting an unchanged information collection package and requesting an extension to the current OMB approval of NMSN Part A to synchronize the expiration date with NMSN Part B.

Respondents: State child support enforcement agencies, employers, and health plan administrators.



### A NNUAL 

### B URDEN 

### E STIMATES

Instrument Number of respondents Number of responses per

respondent Average burden hours per response Total burden hours

National Medical Support Notice—Part A—Notice To Withhold for Health

Care Coverage ............................................................................................. 54 97,775 0.17 897,57 4.50

Estimated Total Annual Burden Hours: 897,574.50.

Additional Information: Copies of the proposed collection may be obtained by writing to the Administration for Children and Families, Office of Planning, Research and Evaluation, 370 L’Enfant Promenade, SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. All requests should be identified by the title of the information collection. Email address: infocollection@acf.hhs.gov

. OMB Comment: OMB is required to make a decision concerning the collection of information between 30 and 60 days after publication of this document in the Federal Register . Therefore, a comment is best assured of having its full effect